BlossomHill Therapeutics (BLSM) Insider & Congress Trades

Smart money at a glance

Filings to Nov 14, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, quarter ended Sep 30, 2026: 2 added, 0 cut
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about BLSM filings

Are insiders buying or selling BlossomHill Therapeutics, Inc. Common Stock (BLSM) stock?

Neither. BlossomHill Therapeutics, Inc. Common Stock (BLSM) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded BLSM recently?

None. No member of Congress disclosed a BLSM trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this BLSM smart-money data?

This summary uses filings available on Nov 14, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

Filings could not be loaded.

6 funds hold a position and insiders have been net buying.

Questions about BLSM filings

Are insiders buying or selling BlossomHill Therapeutics, Inc. Common Stock (BLSM) stock?

Neither. BlossomHill Therapeutics, Inc. Common Stock (BLSM) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded BLSM recently?

None. No member of Congress disclosed a BLSM trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this BLSM smart-money data?

Funds

What funds are doing

2 moves · 6 mo

Buys/Adds$49.4M

Buys/Adds (2)

JC
JPMorgan Chase
Q3 2026 13F
$30.2M
bought
Signals like this: n=3228, 54% finished lower at D15, median -0.8% vs SPY -0.4%
FM
FMR LLC
Q3 2026 13F
$19.1M
bought

Unlock everything for $29/month

Unlock for $29/month

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K Every filing

No earnings history.

Next report

Estimated report: Dec 18, 2026, in 34 days

Estimates as of Nov 13, 2026

EPS expected

-$0.90

-$0.92 to -$0.88

Estimate drift

0.90

Change in 30 days

Open: $15.74
High: $16.10
Low: $14.51
Prev close: $16.12
52-wk high: $27.99
52-wk low: $11.02
Mkt cap: $512.4M
ROE: +0.0%
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $512M

Valuation

Quality

Operating margin0.0%
ROE0.0%
ROA0.0%

Growth

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

35 / 100

RSI 14

51balanced

20D volatility

113%annualized

52-week range

$14.84

$11.02$27.99

20D support

$11.02recent floor

20D resistance

$17.53recent ceiling

Returns

5D +20.2%20D -0.9%60D -8.2%

Price vs moving averages

SMA20 +2.8%SMA50 -18.1%

Volume pace

0.75xvs prior 20D

Smart money at a glance

Filings to Nov 14, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, quarter ended Sep 30, 2026: 2 added, 0 cut
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about BLSM filings

Are insiders buying or selling BlossomHill Therapeutics, Inc. Common Stock (BLSM) stock?

Neither. BlossomHill Therapeutics, Inc. Common Stock (BLSM) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded BLSM recently?

None. No member of Congress disclosed a BLSM trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this BLSM smart-money data?

Filings could not be loaded.

6 funds hold a position and insiders have been net buying.

Questions about BLSM filings

Are insiders buying or selling BlossomHill Therapeutics, Inc. Common Stock (BLSM) stock?

Neither. BlossomHill Therapeutics, Inc. Common Stock (BLSM) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded BLSM recently?

None. No member of Congress disclosed a BLSM trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this BLSM smart-money data?

Funds

What funds are doing

2 moves · 6 mo

Buys/Adds$49.4M

Buys/Adds (2)

JC
JPMorgan Chase
Q3 2026 13F
$30.2M
bought
Signals like this: n=3228, 54% finished lower at D15, median -0.8% vs SPY -0.4%
FM
FMR LLC
Q3 2026 13F
$19.1M
bought

Unlock everything for $29/month

Unlock for $29/month

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K Every filing

No earnings history.

Next report

Estimated report: Dec 18, 2026, in 34 days

Estimates as of Nov 13, 2026

EPS expected

-$0.90

-$0.92 to -$0.88

Estimate drift

0.90

Change in 30 days

Open: $15.74
High: $16.10
Low: $14.51
Prev close: $16.12
52-wk high: $27.99
52-wk low: $11.02
Mkt cap: $512.4M
ROE: +0.0%
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $512M

Valuation

Quality

Operating margin0.0%
ROE0.0%
ROA0.0%

Growth

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

35 / 100

RSI 14

51balanced

20D volatility

113%annualized

52-week range

$14.84

$11.02$27.99

20D support

$11.02recent floor

20D resistance

$17.53recent ceiling

Returns

5D +20.2%20D -0.9%60D -8.2%

Price vs moving averages

SMA20 +2.8%SMA50 -18.1%

Volume pace

0.75xvs prior 20D

BlossomHill Therapeutics, Inc. Common Stock

Smart money at a glance

What do analysts expect?

Questions about BLSM filings

Questions about BLSM filings

What funds are doing

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Results versus expectations

Estimated report: Dec 18, 2026, in 34 days

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

BlossomHill Therapeutics, Inc. Common Stock

Smart money at a glance

What do analysts expect?

Questions about BLSM filings

Questions about BLSM filings

What funds are doing

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Results versus expectations

Estimated report: Dec 18, 2026, in 34 days

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

BlossomHill Therapeutics, Inc. Common Stock

Overview

Questions about BLSM filings

Smart money

Unlock everything for $29/month

Earnings

Financials

Technicals

Ask it in Claude or ChatGPT.

BlossomHill Therapeutics, Inc. Common Stock

Overview

Questions about BLSM filings

Smart money

Unlock everything for $29/month

Earnings

Financials

Technicals

Ask it in Claude or ChatGPT.